- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04903808
Clinical And Cost- Effectiveness of Allium Sativum Oil (Garlic Oil ) Versus Mineral Trioxide Aggregate in Primary Molars Pulpotomy in Group of Egyptian Children : A Randomised Clinical Pilot Study.
August 19, 2021 updated by: Lobna Magdy, Cairo University
Clinical And Cost- Effectiveness of Allium Sativum Oil Versus Mineral Trioxide Aggregate in Primary Molars Pulpotomy in Group of Egyptian Children : A Randomised Clinical Pilot Study.
Allium Sativum oil is advocated to prove the capability of new natural products in replacing higher cost pharmacological materials, while achieving the same successful clinical and radiographic long-term results.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
One of the most challenging subjects in paediatric dentistry is choosing the ideal pulp medication material that has the required properties such as preserving the vitality of the remaining intact pulp and stimulating its repair.
This material should prevent pathological root resorption.Clinical and cost effectiveness trials from different countries are useful to determine which medicament should be advocated in which economic setting .
Alternative pulpotomy materials clinically effective as MTA but with lower cost should be studied .
Study Type
Interventional
Enrollment (Anticipated)
26
Phase
- Phase 2
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 7 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Apparently healthy children aged from 5- 7 years.
- Children not having antibiotics in the past 14 days.
- Cooperative children.
- Children are having at least two carious asymptomatic second primary molars.
Exclusion Criteria:
- Uncooperative children.
- Immunocompromised children.
- Children with clinical or radiographic symptoms
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Allium sativum oil
The pulp stumps of the molars are dressed with a cotton pellet that is made damp with Allium Sativum oil for 1 min .
|
Garlic oil Captain Company (CAP-PHARM)
Other Names:
|
Active Comparator: Mineral Trioxide Aggregate
The material will be prepared according to the manufacturer's instructions , applied to the pulp chamber and a moistened cotton pellet was placed over the MTA paste to allow the material to set.
|
ProRoot MTA, Dentsply
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical effectiveness
Time Frame: 1 year follow up
|
clinical effectiveness will be measured by intraoral examination and radiographic assessment
|
1 year follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cost-effectiveness
Time Frame: 1 year follow up
|
cost-effectiveness will be measured with incremental cost-effectiveness ratio (ICER)
|
1 year follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 1, 2021
Primary Completion (Anticipated)
October 1, 2022
Study Completion (Anticipated)
October 1, 2022
Study Registration Dates
First Submitted
May 20, 2021
First Submitted That Met QC Criteria
May 25, 2021
First Posted (Actual)
May 27, 2021
Study Record Updates
Last Update Posted (Actual)
August 25, 2021
Last Update Submitted That Met QC Criteria
August 19, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Lobnamagdy128
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carious Primary Molars
-
Mansoura UniversityCompletedDecayed Primary MolarsEgypt
-
University GhentCompletedExtensively Decayed Primary MolarsBelgium
-
Hadassah Medical OrganizationActive, not recruitingPulpotomies on Primary MolarsIsrael
-
Ahmad ElheenyCompletedIatrogenic Perforation of Primary MolarsEgypt
-
Minia UniversityCompletedInfected Root Canals of Primary Molars
-
Ahmad ElheenyCompletedRoot Canal Preparation of Infected Primary MolarsEgypt
-
Cairo UniversityUnknownBadly Decayed Lower First Primary Molars in Children
-
Ahmad ElheenyCompletedRestoration of Primary Molars With CAD/CAM CrownsEgypt
-
University GhentCompleted
-
Istanbul UniversityCompletedExtensive Decay in Primary Molars
Clinical Trials on Allium Sativum Oil
-
Suez Canal UniversityCompleted
-
Arslan SaleemBaqai Medical UniversityActive, not recruiting
-
Silliker, Inc.National Center for Complementary and Integrative Health (NCCIH)Unknown
-
University of Health Sciences LahoreLahore General HospitalCompletedNon-Vital ToothPakistan
-
En Chu Kong HospitalRecruitingHydronephrosis | Ureteral Stent Occlusion | Ureteral StenosisTaiwan
-
Allium, Ltd.WithdrawnMalignant Obstruction of the Common Bile DuctIsrael
-
Bayero University Kano, NigeriaPhysiotherapy AssociatesCompleted
-
University of Health Sciences LahoreLahore General HospitalCompletedAllium Sativum Oil and Turmeric Gel as Alternative Non-vital Pulpotomy Medicaments in Primary Teeth.Non Vital TeethPakistan
-
Hanyang UniversityActive, not recruitingUpper Respiratory InfectionKorea, Republic of
-
Hospices Civils de LyonCompletedDetrusor Striated Sphincter Dyssynergia (DSSD)France